
Steroids and hormone therapies
*Disclaimer: This article was published in 2019 and reflects the information available at that time. Off Label Use or Misuse/Abuse Pharmacists are expected to have
Practice Alerts Page 16
*Disclaimer: This article was published in 2019 and reflects the information available at that time. Off Label Use or Misuse/Abuse Pharmacists are expected to have
*Disclaimer: This article was published in 2019 and reflects the information available at that time. Set rules early The provision of medicines via a staged
*Disclaimer: This article was published in 2019 and reflects the information available at that time. The colder weather sees a predictable increase in the
*Disclaimer: This article was published in 2019 and reflects the information available at that time. Over 10% of incidents reported to PDL involve the
*Disclaimer: This article was published in 2019 and reflects the information available at that time. With the influenza season fast approaching, demand on pharmacist
*Disclaimer: This article was published in 2019 and reflects the information available at that time. At the end of the My Health Record (MHR)
*Disclaimer: This article was published in 2019 and reflects the information available at that time. A number of incidents reported to PDL in recent
*Disclaimer: This article was published in 2018 and reflects the information available at that time. Sooner or later most pharmacists can expect to be
*Disclaimer: This article was published in 2018 and reflects the information available at that time. When a prescription is dispensed, the Pharmacy Board expects
*Disclaimer: This article was published in 2018 and reflects the information available at that time. Recently, a notification was made to the Australian Health
Pharmaceutical Defence Limited (PDL) acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to land, waters and community. We pay our respects to the people, the cultures and the Elders past and present.